Modeling Evolutionary Dynamics of HIV Infection

Luca Sguanci, Pietro Liò, Franco BagnoliCMSB 2006 · OpenReview

Abstract

We have modelled the within-patient evolutionary process during HIV infection. We have studied viral evolution at population level (competition on the same receptor) and at species level (competitions on different receptors). During the HIV infection, several mutants of the virus arise, which are able to use different chemokine receptors, in particular the CCR5 and CXCR4 coreceptors (termed R5 and X4 phenotypes, respectively). Phylogenetic inference of chemokine receptors suggests that virus mutational pathways may generate R5 variants able to interact with a wide range of chemokine receptors different from CXCR4. Using the chemokine tree topology as conceptual framework for HIV viral speciation, we present a model of viral phenotypic mutations from R5 to X4 strains which reflect HIV late infection dynamics. Our model investigates the action of Tumor Necrosis Factor in AIDS progression and makes suggestions on better design of HAART therapy.

Introduction

HIV infection is characterized by the presence of a "quasispecies"—a diverse cloud of related viral mutants within a single host. A pivotal moment in disease progression is the coreceptor switch. Early in infection, the virus typically utilizes the CCR5 coreceptor (R5 phenotype). However, in approximately half of patients, the virus evolves to use the CXCR4 coreceptor (X4 phenotype). This switch is clinically significant as it correlates with accelerated progression to AIDS. Understanding how these strains co-evolve and compete is essential for developing effective therapies, especially as new drugs targeting specific coreceptors emerge.

Methods

The researchers extended the standard model of HIV dynamics to develop two distinct frameworks. The QSR5 Model focuses on the early infection phase, analyzing competition between multiple R5 strains and the immune system's response to various viral epitopes. The R5toX4 Model tracks the transition to the X4 phenotype by incorporating the dynamics of Tumor Necrosis Factor (TNF). TNF is a signaling protein that inhibits R5 replication while simultaneously boosting X4 infectivity and accelerating the depletion of T-cell precursors in the thymus.

Schematic of the R5toX4 model illustrating interactions between T-cells, virus, and TNF.

The study integrated biological parameters synthesized from medical literature, such as mutation rates (approx. $10^{-5}$) and viral clearance rates. Additionally, phylogenetic inference was performed on human and mouse chemokine receptor sequences to map the evolutionary "distance" and potential pathways the virus traverses during the R5 to X4 transition.

Results and Discussion

The model reveals that the switch to X4 is reinforced by a biological feedback loop: X4 strains stimulate TNF production, which suppresses R5 competitors and destroys immature T-cells. This "clearing of the field" facilitates X4 dominance and immune system collapse. Furthermore, the simulation demonstrates "quasispecies speciation," where immune pressure forces a single viral population to split into distinct clusters.

Simulation results showing viral speciation and T-cell dynamics over time.

Key findings include:

  • Slow-Motion Evolution: Following superinfection, it can take several months for a new strain to reach equilibrium, a process that slows further as CD4+ T-cell counts decline.
  • HAART Interruption Risks: Stopping therapy can accelerate the emergence of X4 strains. During viral rebound, R5 mutants closer to the X4 phenotype space can rapidly repopulate the host.
  • Clinical Replication: The R5toX4 model successfully replicates the slow, continuous decline in CD4+ T-cells observed clinically, reaching the AIDS threshold (below 200 cells/µl) as X4 strains become dominant.

Conclusion

The proposed models provide a robust framework for understanding HIV's evolutionary dynamics. The inclusion of TNF dynamics highlights its critical role in T-cell depletion and viral phenotypic switching. Future research will focus on incorporating fluctuating TRAIL (TNF-related apoptosis-inducing ligand) dynamics and exploring "TNF buffering therapy" as a potential strategy to mitigate T-cell loss and slow disease progression.

Summary updated

Abstract

We have modelled the within-patient evolutionary process during HIV infection. We have studied viral evolution at population level (competition on the same receptor) and at species level (competitions on different receptors). During the HIV infection, several mutants of the virus arise, which are able to use different chemokine receptors, in particular the CCR5 and CXCR4 coreceptors (termed R5 and X4 phenotypes, respectively). Phylogenetic inference of chemokine receptors suggests that virus mutational pathways may generate R5 variants able to interact with a wide range of chemokine receptors different from CXCR4. Using the chemokine tree topology as conceptual framework for HIV viral speciation, we present a model of viral phenotypic mutations from R5 to X4 strains which reflect HIV late infection dynamics. Our model investigates the action of Tumor Necrosis Factor in AIDS progression and makes suggestions on better design of HAART therapy.
BibTeX
@inproceedings{sguanci2006modeling,
  author = {Luca Sguanci and Pietro Liò and Franco Bagnoli},
  title = {{Modeling Evolutionary Dynamics of HIV Infection}},
  booktitle = {CMSB},
  year = {2006},
  url = {https://openreview.net/forum?id=yNCogzkpGL0},
}
Figure